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1. Introduction 
The prevalence of adults with congenital heart disease is rising in the general population (1). 
Similarly, the number of geriatric patients with congenital heart disease, such older than 70 
years old, is also rising. Furthermore, mortality rates in congenital heart disease have shifted 
away from the young and towards adults, with a steady increase in age at death. Actually, the 
mortality of congenital heart disease in patients whose age 60 years or more is increasing 
during past few decades reported in Japanese nationwide survey (2). Atrial septal defect 
(ASD) is the one of the most common congenital heart lesions in adults, and the most 
influenced heart disease for the death in geriatric population. Prevalence of ASD in children is 
noted to be 11.4% within the congenital heart defects (3). Majority of these children are 
asymptomatic and diagnosed by school physical examination, heart murmur detected primary 
care pediatrician, cardiac echo screening in the newborn period. If defect is smaller than 6 mm, 
spontaneous closure can be expected. Operation is scheduled based on children’s body size, 
usually before the elementally school with very low incidence of mortality rate (4). 
Although the pediatric or young adult ASD population has attracted research interest over 
the last 2 decades, the geriatric ASD population has yet to be characterized. Extrapolation of 
studies on younger patients is not appropriate in the geriatric patients. First, geriatric 
patients with ASD acquire comorbid conditions such as arrhythmia, hypertension, 
respiratory distress, kidney disease, etc., that always influence on significant role in their 
heart conditions. Second, geriatric ASD patients may have inherently superior resiliency, 
milder disease, or balanced physiology in contrast to those not surviving to an advanced age 
(5). Therefore, geriatric patients with ASD represent a distinct population for which focused 
studies are needed. 
Again, clinical features of atrial septal defect (ASD) in the elderly are significantly different 
from those in children and young adults. Elderly patients with ASD frequently present with 
hemodynamic abnormalities such as pulmonary hypertension, atrial arrhythmias, and 
valvular regurgitation, which cause congestive heart failure. Moreover, various 
comobidities, such as hypertension, chronic obstructive pulmonary disease, coronary artery 
disease and left ventricular diastolic dysfunction often complicate the clinical features in this 
population. Left ventricular diastolic dysfunction, which is also seen as part of normal aging 
and frequently occurs in elderly individuals with hypertension or increased arterial stiffness 
[6,7], may cause acute congestive heart failure after ASD closure [8].  
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After the introduction of Amplatzer Septal Occluder, transcatheter ASD closure has become 
a well-established treatment for secundum-type ASD, with hemodynamically significant 
left-to-right shunt in children and young adults. Several studies and our own experience 
have demonstrated clinical benefits and positive right-heart remodeling, with reduction of 
the right ventricular end-diastolic diameter.(8-17) However, few studies were published 
considering geriatric patients, who older than 70 years.(18–21) In this aged population, not 
only catheter closure of ASD but also surgical closure has been reported very limited 
experiences, little data are published on functional results. In this chapter, I would like to 
report our current experience of catheter closure of ASD in geriatric patients (70 years or 
more), and its long-term outcome.  
2. Patient’s background 
From 2005 to 2010, transcatheter closure of ASD was attempted in 420 patients in our 
hospital. Of those patients, 30 patients who were older than 70 years were retrospectively 
assessed. Patient characteristics, clinical, hemodynamic and echocardiographic data, and 
ASD morphology are shown in Table 1. There were 10 males and 20 females with a mean  
 
Total patients 30 
Gender, F/M  20/10 
Age, (range), yrs 75.8 ± 3.8 (70-85) 
BSA, m2 1.5 ± 0.2 
Hypertension 12 (40%) 
Stroke 4 (13%) 
CAD 2 (7%) 
COPD 5 (17%) 
Atrial fibrillation 16 (53%) 
   Paroxysmal 3 (10%) 
   Permanent 13 (43%) 
RBBB 22 (74%) 
Systolic PAP *, mmHg 35.6 ± 11.8 
PAH 16 (53%) 
E', cm/s 7.1 ± 1.9 
E/E` 11.0 ± 3.9 
Diuretic use 17 (57%) 
Hospitarization for HF 9 (30%) 
NYHA functional class, I / II / III 5 /17 / 8 
Qp/Qs* 2.4 ± 0.7 
ASD size, mm 20.3 ± 6.4 
Rim type 
 
  Sufficient rim, n (%) 8 (27%) 
  Aortic rim deficient, n (%) 19 (63%) 
  Aortic and anterosuperior rim deficient, n (%) 1 (3%) 
  IVC rim deficient, n (%) 2 (7%) 
BSA, body surface area; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease 
RBBB, right bundle branch block;  PAP, pulmonary artery pressure; PAH, pulmonary artery 
hypertension 
E, early diastolic mitral valve flow velocity; E', early diastolic mitral annular velocity; HF, heart failure 
NYHA, New York Heart Association; Qp, pulmonary flow; Qs, systemic flow; IVC, inferior vena cava 
Table 1. Patients Characteristics 
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age of 75.8 ± 3.8 years and age range of 70 to 85 years. Eighteen of the 30 patients had been 
diagnosed with ASD within 2 years before transcatheter closure was attempted but the 
others well before that. Most of the patients had at least one major comorbidity, including 
systemic hypertension, stroke, coronary artery disease, and atrial fibrillation. Mean systolic 
pulmonary artery pressure at the time of diagnostic catheterization was 35.6 ± 11.8 mmHg. 
Mean early diastolic mitral annular velocity (e') and the ratio of early diastolic mitral valve 
flow velocity (E) to e' (E/e') suggested that our cohort generally had impaired myocardial 
relaxation.(22,23) Twelve patients had been diagnosed with ASD well before transcatheter 
closure was attempted but they had refused or hesitated to receive ASD closure. We think 
that this was partially because they had no recognizable symptom, but mainly because 
surgical closure was the only treatment at the time when they had been first diagnosed with 
ASD. More than half of the patients were being treated with a diuretic for congestive heart 
failure, and 30% of the patients had a history of hospitalization due to heart failure. 
Seventeen patients were classified as NYHA functional class II and 8 patients were classified 
as class III. Only 5 patients had no symptoms despite significant shunt flow and were 
classified as NYHA functional class I. One patient had two defects. Mean defect diameter 
was 20.3 ± 6.4 mm, and a circumferentially sufficient rim (> 5 mm rim around the defect) 
was observed in only 8 patients. Mean pulmonary-systemic flow ratio (Qp/Qs) calculated 
by using the Fick principle was 2.4 ± 0.7.  
3. Hemodynamic features during ASD closure in geriatric patients 
Previous studies have suggested that development of acute congestive heart failure is due to 
abrupt elevation in left ventricular preload following transcatheter ASD closure, especially in 
elderly patients with impaired left ventricular systolic or diastolic function (6,24,25) In our 
experience, despite the fact that our patients had impaired left ventricular diastolic function 
estimated by decreased e' and increased E/e' (23,26) as well as various comorbidities such as 
systemic hypertension, pulmonary artery hypertension and atrial fibrillation, acute congestive 
heart failure after the ASD closure did not develop in any of the patients except in one patient 
in whom the procedure was abandoned due to PCWP elevation during test balloon occlusion. 
Schubert et al. reported that peri-procedural anticongestive medication was effective in 
preventing congestive heart failure after ASD closure in elderly patients (27). In our 
experience, 57% of the 30 patients previously used oral diuretics, and this high rate of diuretic 
usage might have contributed to prevention of acute congestive heart failure after closure. 
4. Transcatheter ASD closure 
Transcatheter ASD closure was conducted under general anesthesia with the guidance of 
fluoroscopy and TEE. Amplatzer® Septal Occluder (St. Jude Medical, St. Paul, MN) was 
used for all closures, and the procedure was performed as previously described (28). For 
patients who had a history of heart failure and were considered to be hemodynamically 
high-risk, we placed a Swan-Ganz catheter into pulmonary artery from the internal jugular 
vein or femoral vein and monitored pulmonary artery wedge pressure (PCWP) during 
subsequent procedure. If mean PCWP increased > 5 mmHg from the baseline value during 
balloon occlusion of the defect (test balloon occlusion), we judged the procedure should not 
be indicated. (Fig. 1) Medications such as diuretics, warfarin, and antihypertension and 
antiarrhythmia drugs were continued at the same doses after the procedure. 
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(a) Chest x ray before the procedure 
 
(b) ECG finings before the procedure 
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(c) apical 4 chamber view of transthoracic echocardiography: RA and RV are significantly enlarged 
 
(d) transesophageal echocardiography demonstrated 30mm defect with aortic rim deficiency 
 
(e) 3d transesophageal echocardiography demonstrated the elliptical shape of ASD 
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(f) Catheter closure of ASD using 34mm device, PCW pressure monitored continuously 
 
(g) Chest x-ray 6 months after the ASD closure, clinical symptoms also resolved completely 
Fig. 1. 82 years old female, ASD with permanent atrial fibrillation. 
www.intechopen.com
 
Atrial Septal Defect Closure in Geriatric Patients 145 
Prior to ASD closure, test balloon occlusion were performed in 7 of 30 cases. As a result, 
the procedure was abandoned in one case due to a significant elevation of PCWP during 
test occlusion of the ASD. This patient was an 84-year-old thin woman who had 
permanent atrial fibrillation, hypertension, chronic kidney disease, chronic anemia and 
severe TR. She had been repeatedly hospitalized with congestive heart failure in  
past years. Her ASD diameter was 24 mm and Qp/Qs was 2.6. During test balloon 
occlusion, her PCWP immediately increased from 8 mmHg to 22 mmHg and remained at 
16 mmHg after 20 minutes, thus procedure was abandoned. In the other 2 cases, the 
device was difficult to deploy because of large size defect. One of those cases proceeded to 
surgical closure, and the other case was successfully closed in the second attempt of 
catheter intervention on a later day. Finally, 28 (93%) of the 30 patients were treated 
successfully by catheter closure. A single device was placed in 27 patients. In the 
remaining patient with multiple defects, 2 devices were deployed at the time of the same 
procedure. Mean device diameter was 23.3 ± 6.0 mm. Mean follow-up period was 19.1 ± 
11.3 months.  
5. Procedural outcomes 
Table 2 shows the procedural and mid-term results. Device closure was successfully 
performed in 28 (93%) of the 30 patients without acute complications. In the other 2 patients, 
the procedures were abandoned because of technical issues. While only 8 (27%) of the 30 
patients had sufficient rim type ASD, 19 (63%) had aortic rim deficient type. However, there 
was not much difference in our device selection between sufficient rim and aortic rim 
deficient type. Therefore, we think that the small percentage of patients with sufficient rim 
did not have a great impact on device size selection in the present study. Although the 
majority of our patients were complicated with various comorbidities, such as pulmonary 
artery hypertension, systemic hypertension and atrial fibrillation, high procedural success 
rate can be expected even in this aged group. Also, significant improvement of NYHA 
functional class was observed after closure even though about 30% of the patients in this  
 
Procedural results (n=30) 
 
 Success deployment, n (%) 28 (93%) 
 Device size, mm 23.3 ± 6.0 
 Acute complication, n (%) 0 (0%) 
Mid-term results (n=28) 
 
 Meam follow-up period, m 19.1 ± 11.3  
 Residual shunt, n (%) 2 (8%) 
 Major events 
 
   Death, n (%) 2 (8%) 
      sudden death, n 1 (4%)* 
      prostate cancer, n 1 (4%) 
   Pacemaker implantation, n (%) 1 (4%) 
   TIA, n (%) 1 (4%)* 
   Persistent AF, n (%) 1 (4%) 
 * the same case 
TIA, transient ischemic attack; AF, atrial fibrillation 
Table 2. Procedural and Mid-term Results  
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study had a history of hospitalization for congestive heart failure. No patient required 
additional hospitalization for congestive heart failure during the follow-up period. The first 
procedure was successful in 27 of 30 cases in which transcatheter ASD closure was 
attempted. On the other hand, the procedure was abandoned in 3 cases.  
Two patients died during the follow-up period. One died of prostatic cancer 20 months after 
ASD closure. The other patient died 2 months after the procedure. This patient was a 70-
year-old woman who had permanent atrial fibrillation, severe chronic obstructive 
pulmonary disease, mild left ventricular dysfunction, history of pacemaker implantation for 
sick sinus syndrome, and mitral valve replacement and was in NYHA functional class III. 
Her ASD was 22 mm with a sufficient atrial rim, and a 26 mm device was used for closure. 
She died from unknown cause at home; however, a history of transient cerebral ischemic 
attack was reported one week before her death. Autopsy was not performed. During the 
follow-up period, 3 complications occurred. One patient who was complicated with several 
cardiac comorbidities died 2 months after the procedure. An autopsy was not performed 
and it was therefore not known whether the cause of sudden death was ASD device-
associated. 
6. Atrial arrhythmias 
Two patients were complicated with new arrhythmia. One patient who had permanent 
atrial fibrillation underwent pacemaker implantation for slow ventricular response 6 
months after ASD closure. The other patient with paroxysmal atrial fibrillation before ASD 
closure developed persistent atrial fibrillation during the follow-up period. The remaining 
24 patients had no late complication during the follow-up period. No patient had 
hemodynamically significant residual shunt.  
Table 3 shows time course changes in clinical and echocardiographic parameters. Follow-up 
data (at more than 6 months after the procedure) were available in all of the 28 patients with 
exception of one patient who died 2 months after the procedure. NYHA functional class was 
significantly improved in 20 (74%) of the 27 patients at the latest follow-up (Fig. 2). One 
patient who remained in NYHA class III was complicated with severe chronic obstructive 
pulmonary disease. There was also a significant improvement in plasma BNP level (175.9 ± 
64.7 vs. 99.2 ± 83.2 pg/ml, P=0.013). Resting heart rate also decreased significantly (74.4 ± 
14.5 vs. 66.7 ± 8.7 beats/min, P=0.005), although no cardiac chronotropic drug was 
administered to any of the patients. Pacemaker implantation was required in one patient 6 
months after the procedure, even though bradycardia was not observed before or just after 
ASD closure. In one patient, paroxysmal atrial fibrillation progressed into persistent atrial 
fibrillation 2 years after ASD closure. In previous studies, the incidence of atrial fibrillation 
in patients after transcatheter ASD closure was estimated to be 5% to 18% (29-31), however, 
especially in elderly patients, atrial fibrillation is one of the expected findings for their 
natural course after ASD closure.   
7. Cardiac remodeling 
RVEDD and estimated systolic pulmonary artery pressure decreased significantly (40.8 ± 6.0 
vs. 31.6 ± 4.5 mm, P<0.001, 38.5 ± 12.7 vs. 27.2 ± 7.3 mmHg, P<0.001, respectively). At the  
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BNP, brain natriuretic peptide; PAP, pulmonary artery pressure; RVEDD, right ventricular end-
diastolic dimension; LAD, left ventricular dimension; LVEF, left ventricular ejection fraction; TR, 
tricuspid regurgitation; MR, mitral regurgitation 
Table 3. Changes of Clinical Echocardiographic Parameters 
 
Fig. 2. NYHA functional class before the procedure and at follow-up.  
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same time, LVEDD increased significantly (39.7 ± 4.8 vs. 45.3 ± 4.6 mm, P<0.001). Therefore, 
the RVEDD/LVEDD ratio significantly decreased (1.05 ± 0.24 vs. 0.70 ± 0.12 mm, reduction 
of 67%, P<0.001), indicating ventricular reverse remodeling. Left atrial dimension, above the 
normal level at baseline, did not change significantly during the follow-up period. Left 
ventricular ejection fraction also did not change. During the follow-up period, NYHA 
functional class significantly improved in 20 (74%) of the 27 patients. Our data also 
demonstrated significant decreases of heart rate, pulmonary artery pressure and plasma 
BNP level, and these changes contributed to the improvement of NYHA functional class. 
Decrement of heart rate is presumably evidence of increment of left ventricular stroke 
volume following increased left ventricular preload after abolishment of left-to-right shunt. 
Significant decrease in RVEDD/LVEDD ratio was observed even in our geriatric patients, 
although RVEDD did not reach the normal level. Interestingly, percentage change in 
RVEDD/LVEDD ratio in our cohort was equivalent to results of other studies in younger 
populations (25,32). Furthermore, it was revealed that RVEDD/LVEDD ratio was 
independently correlated with NYHA functional class in the follow-up period. 
8. AV valve regurgitation 
Improvement of TR was observed in 11 of 17 patients (65%) with moderate or severe degree 
of regurgitation during the follow-up period (Fig. 3). On the other hand, MR was increased 
in 10 (37%) of the 27 patients and was unchanged in the others (63%) during the follow-up 
period (Fig. 4). In our cohort, there was no patient with mitral valve prolapse as a cause for 
MR. In this study, the degree of TR was decreased in 11 patients (41%) and exacerbation of  
 
 
 
 
Fig. 3. Degrees of TR before the procedure and at follow-up. 
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Fig. 4. Degrees of MR before the procedure and at follow-up.  
TR was not observed during the follow-up period. Interestingly, in the case of moderate or 
severe TR before ASD closure, the degree of TR was improved in 11 (65%) of the 17 patients. 
TR can be improved functionally following decrement of right ventricular preload after ASD 
closure. Improvement of TR also can be expected following improvement of right 
ventricular geometric abnormality (33,34). Our results suggest that TR can be improved 
even in geriatric patients and that the severity of TR does not become a factor to exclude 
them as candidates for transcatheter ASD closure. On the other hand, the degree of MR was 
slightly increased in 10 patients (37%) and unchanged in the others (63%) during the follow-
up period. Wilson et al. reported that the degree of MR was unchanged in 83% and 
increased in 10% of their 194 patients, including 78 patients aged younger than 15 years, 
after transcatheter ASD closure (35). In elderly ASD patients, the severity of MR might be 
masked by the presence of ASD effectively reducing left ventricular preload. Additionally, 
degenerated change of the mitral valve leaflet also influenced the increase in MR. Although 
the degree of MR and the increase in MR were not associated with NYHA functional class in 
the follow-up period in our study, further long-term follow-up is mandatory. 
Associations between NYHA functional class and echocardiographic parameters in the 
follow-up period  
Table 4 shows associations of clinical and echocardiographic parameters with NYHA 
functional class. In the follow-up period, RVEDD/LVEDD ratio was identified as a factor 
associated with NYHA functional class. On the other hand, E/e', e', degree of TR or MR and 
increase in MR were not associated with NYHA functional class.  
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Table 4. Association betwwen Clinical and Echocardiographic Parameters and NYHA class 
at Follow-up Period 
9. Conclusions 
Although our experience is still small, even in elderly patients older than 70 years, 
transcatheter closure of ASD can be performed safely and contributes to significant 
improvement of NYHA functional class and positive cardiac remodeling. Further 
investigation is required especially for the outcome of MR 
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Atrial Septal Defects (ASDs) are relatively common both in children and adults. Recent reports of increase in
the prevalence of ASD may be related use of color Doppler echocardiography. The etiology of the ASD is
largely unknown. While the majority of the book addresses closure of ASDs, one chapter in particular focuses
on creating atrial defects in the fetus with hypoplastic left heart syndrome. This book, I hope, will give the
needed knowledge to the physician caring for infants, children, adults and elderly with ASD which may help
them provide best possible care for their patients.
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